These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12067408)

  • 1. Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway.
    Monji T; Petersons J; Saund NK; Vuckovic S; Hart DN; Auditore-Hargreaves K; Risdon G
    Immunol Cell Biol; 2002 Jun; 80(3):216-25. PubMed ID: 12067408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
    Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
    J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B; Camus S; Yagello M; Gluckman JC
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
    Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C
    J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.
    Canque B; Camus S; Yagello M; Gluckman JC
    J Leukoc Biol; 1998 Aug; 64(2):235-44. PubMed ID: 9715264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells.
    Ryncarz RE; Anasetti C
    Blood; 1998 May; 91(10):3892-900. PubMed ID: 9573027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.
    Caux C; Vanbervliet B; Massacrier C; Dezutter-Dambuyant C; de Saint-Vis B; Jacquet C; Yoneda K; Imamura S; Schmitt D; Banchereau J
    J Exp Med; 1996 Aug; 184(2):695-706. PubMed ID: 8760823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy.
    Fearnley DB; McLellan AD; Mannering SI; Hock BD; Hart DN
    Blood; 1997 May; 89(10):3708-16. PubMed ID: 9160676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type.
    Herbst B; Köhler G; Mackensen A; Veelken H; Kulmburg P; Rosenthal FM; Schaefer HE; Mertelsmann R; Fisch P; Lindemann A
    Blood; 1996 Oct; 88(7):2541-8. PubMed ID: 8839846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
    Pickl WF; Majdic O; Kohl P; Stöckl J; Riedl E; Scheinecker C; Bello-Fernandez C; Knapp W
    J Immunol; 1996 Nov; 157(9):3850-9. PubMed ID: 8892615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1.
    Lardon F; Snoeck HW; Berneman ZN; Van Tendeloo VF; Nijs G; Lenjou M; Henckaerts E; Boeckxtaens CJ; Vandenabeele P; Kestens LL; Van Bockstaele DR; Vanham GL
    Immunology; 1997 Aug; 91(4):553-9. PubMed ID: 9378494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo generation of functional dendritic cells from mobilized CD34+ hematopoietic stem cells.
    Min YH; Lee ST; Choi KM; Chong SY; Kim HO; Hahn JS; Ko YW
    Yonsei Med J; 1998 Aug; 39(4):328-38. PubMed ID: 9752799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression.
    Bernhard H; Huseby ES; Hand SL; Lohmann M; Batten WY; Disis ML; Gralow JR; Meyer zum Büschenfelde KH; Ohlén C; Cheever MA
    Immunobiology; 2000 Apr; 201(5):568-82. PubMed ID: 10834314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.
    Strobl H; Riedl E; Scheinecker C; Bello-Fernandez C; Pickl WF; Rappersberger K; Majdic O; Knapp W
    J Immunol; 1996 Aug; 157(4):1499-507. PubMed ID: 8759731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor.
    Arrighi JF; Hauser C; Chapuis B; Zubler RH; Kindler V
    Blood; 1999 Apr; 93(7):2244-52. PubMed ID: 10090933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.